David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner,

Slides:



Advertisements
Similar presentations
Integration of Behavioral Health Services with Primary Care Presented by: Sharon Beaty.
Advertisements

Overnight Corneal Reshaping (Orthokeratology) in Adolescents S. Lance Forstot, MD, FACS The author has no financial interest in the subject matter of this.
Familial corneal patterns in pellucid marginal degeneration: uncovering a possible etiology Hajirah N. Saeed, MD.
Ocular Manifestations Stella K. Kim, M.D. MD Anderson Cancer Center Houston, TX Michael R. Robinson, M.D. National Eye Institute National Institutes of.
Mohd Shafiq Bin Paridin Mohd. Firdaus Bin Jamalullail Nik Mohd Abduh Bin Nik Mhd Nor 4 th Year Medical Student Faculty Of Medicine, Zagazig University.
Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.
Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
1 KEEP YOUR EYES OPEN! Untreated co-morbidities in adults with Epilepsy and Learning Disability Authors; Flinton L, Pashley S, Lewington E.
Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Eyelid, Periorbital, and Ocular Surface Temperature Differences Between Sjögren’s Eyes and Asymptomatic Controls Holly B. Hindman 1,2, Christine Callan.
Epitheliopathy in the Region of the Eyelid Associated with the Caruncle in Normal Subjects and Dry-Eye Patients Epitheliopathy in the Region of the Eyelid.
Evaluation of Adjuvant Role of Amniotic Membrane Transplantation in Acute Stevens Johnson Syndrome With Medical Therapy in a Randomized Controlled Study.
Grand Rounds Scleromalacia Amir R. Hajrasouliha, M.D. University of Louisville Department of Ophthalmology and Visual Sciences Friday, January 17, 2014.
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
Bilateral Corneal Trophic Ulcers and Subsequent Infectious Keratitis in a Patient with Graft-versus-host Disease Yonca Aydın Akova, MD Bayındır Hospital,
Sponsored by the National Eye Institute,
Siamak Zarei-Ghanavati M.D., FICO
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
Long term ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children Asim Ali, MD, FRCSC Kamiar Mireskandari, MD,
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Copyright restrictions may apply Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related.
Repeatability of Anterior and Posterior Corneal Higher- Order Aberrations in 4 mm, 6 mm and 8 mm diameters measured by Pentacam System Jadwiga Wojtowicz.
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
Autologous serum eye drops in severe post-LASIK dry eye.
Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
Vision related quality of life in persons with Dry eye syndrome using the 25 item National eye Institute visual function questionnaire S.P. Mahesh MD Janine.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
U N I V E R S I T Y O F M I C H I G A N S C H O O L O F D E N T I S T R Y 1 Quality Assessment and Assurance of Clinical Care Programs.
Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.
Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.
Prospective Correlation of Symptoms and Clinical Grading in Vernal Keratoconjunctivitis Patients Srikant K Sahu, Shraddha Pawan Sureka, Sujata Das, Apurva.
Management of Mycotic Keratitis
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
E-Poster Price Vision Group & Cornea Research Foundation of America Descemet - Stripping Endothelial Keratoplasty :Survival Outcomes in Eyes with Pre-
How To Design a Clinical Trial
1 Observations from Past Approvals for Acute Bacterial Sinusitis Janice Pohlman, M.D. AIDAC Meeting, October 29, 2003.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Correlation of Conjunctival and Corneal Staining With Elevated Matrix Metalloproteinase-9 on the Ocular Surface of Dry-Eye Patients Authors: Allister Gibbons,
Topical Cyclosporine 0.05% as a Long-Term Monotherapy for Atopic Keratoconjunctivitis Jonathan H. Tzu, M.D ¹, * ; C. Asli Utine, M.D ¹,², * Michael Stern,
Outcome of cataract surgery in Scleritis patients Bhupesh Bagga Cornea & Anterior Segment Department L.V.Prasad Eye Institute, Hyderabad,India Financial.
Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease Okada AA, Goto H, Ohno S, Mochizuki M; Ocular Behçet’s Disease Research.
Familial corneal patterns in pellucid marginal degeneration: uncovering a possible etiology Hajirah N. Saeed, M.D., Amy B. Rosenfeld Ph.D., Xiaowu Gai,
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
RED EYE SYNDROM.
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
ID: 287 Fusarium keratitis in a tertiary eye care centre in India Sujata Das, MS, FRCS Savitri Sharma, MD Samir Mahapatra, MS Srikant K Sahu, MS L V Prasad.
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
Six-Year Longevity of Selective Laser Trabeculoplasty as Primary Therapy in Patients with Glaucoma ASCRS 2009 Lawrence F. Jindra, MD Columbia University.
Nursing Process n116. The Nursing Process  Assessment  Diagnosis  Planning  Implementing  Evaluating.
How To Design a Clinical Trial
5 Different Observational Datasets: Pros & Cons
Mapping and UTILIZATION of health care services from patients with newLY DiagnosED systemic lupus erythematosus Rapsomaniki P.1, Terizaki M.1, Kabouraki.
Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD
مقدمه في الرعايه الصحية HHSM301
Sarosh A. Janjua MD1, Sandra L. Cremers MD FACS1
اصول نگارش پرونده های پزشکی
Seasonal Allergic Rhinitis
جامعة الملك عبد العزيز كلية الاعمال رابغ
Tips for Written assignment HSNS265
ASCRS, San Francisco, CA, April 3-8, 2009
Visual Outcomes and Satisfaction with Toric IOL Versus Monofocal IOL
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner, Parekh, Shamie and White are consultants for Inspire. Mr Schiewe is an employee of Inspire. Affiliations: 1 University of Minnesota; 2 Yale University Medical School; 3 The New York Eye and Ear Infirmary; 4 Doheny Eye Institute and the USC Keck School of Medicine; 5 Skyvision Centers; 6 Inspire

2  The purpose of this retrospective study was to identify trends in the diagnosis, recorded findings and treatment of patients presenting with symptoms of Ocular Surface Disease (OSD).

3  This study was a multi-center, retrospective study  52 sites were involved in the study, emphasizing general practice Eye Care Professionals (77% MD and 23% OD).  1157 patient charts  Patients presented with symptoms of ocular surface disease consecutively at the site over an 8 week period.  Retrospective chart review  Inclusion criteria – a primary diagnosis of either bacterial/viral conjunctivitis, blepharitis or dry eye  Exclusion criteria – patients diagnosed with allergic conjunctivitis were excluded from the study in order to avoid a bias due to allergy season

4  Data collection form utilized to capture information from patient charts:  OSD symptoms (severity ratings)  OSD signs (severity ratings)  Assessments & Tests (visual acuity, staining, tear break-up time, Schirmer and cultures)  Treatments (mechanical therapy, OTC, nutraceuticals, pharmaceuticals)

5 Blepharitis alone Dry Eye alone Conjunctivitis (Bacterial/Viral) alone Blepharitis and Dry Eye Other mixed diagnosis n = % 6% 29% 6% 26%

6 * includes subjects with a primary diagnosis of Conjunctivitis 35% 28% 37% Conjunctivitis n = 72 Bacterial Viral Undetermined

7 Subclassification of Primary Diagnosis* * includes subjects with a primary diagnosis of Blepharitis or Dry Eye Blepharitis Dry Eye Anterior n = % n = 384 Anterior and Posterior Posterior Non-differentiated 18% 24% 36% 10% 4% 32% 54% Non-differentiated Evaporative Aqueous Deficient and Evaporative Aqueous Deficient

8 * Primary Diagnosis Only - Blepharitis: n=300; Dry Eye: n=384; Conjunctivitis: n= 72

9 Anterior Posterior * Primary Diagnosis Only - Blepharitis: n=300; Dry Eye: n=384; Conjunctivitis: n= 72 Evaluation of the Eyelid

10 * Primary Diagnosis Only - Blepharitis: n=300; Dry Eye: n=384; Conjunctivitis: n= 72

11 * Primary Diagnosis Only - Blepharitis: n=300; Dry Eye: n=384; Conjunctivitis: n= 72 ** “Other” includes: patient education, referral, MG probing and intense pulsed light

12  Ocular surface disease encompasses a broad range of diagnoses.  Results indicate that symptoms of the various forms of OSD overlap to a large degree on initial presentation.  Although symptoms are important to the patient, proper identification of clinical findings provides the basis for a differential diagnosis and for identifying optimum management.  Corneal staining was the most common assessment utilized in the diagnosis of primary conditions of Conjunctivitis, Dry Eye and Blepharitis.  Signs of patients with the primary diagnosis of blepharitis or conjunctivitis share signs from the anterior evaluation of the eyelids (debris, hyperemia, swelling). However, this is not true of signs from the posterior evaluation of the eyelids.  Management practices were dependant on the primary diagnosis.